Dr. Susan Boackle discusses the medications used to treat lupus and research underway to identify markers that can predict who might develop lupus or go into a disease flare.
Dr. Brad Rovin discusses how lupus nephritis is diagnosed and treated, and the special considerations women with lupus who wish to become pregnant need to consider.
Ask The Experts: Dr. Emily Von Scheven presents on steroid use in children with lupus
Anifrolumab significantly reduced disease activity as measured by several SLE composite endpoints and improved symptoms of lupus.
A new analysis of data from a phase II clinical study of Edratide support the need for additional longer term studies in lupus.
Treat-to-Target is a treatment approach that has been used successfully in other diseases, including rheumatoid arthritis and diabetes. An international group of lupus experts has developed a set of recommendations for using this principle in lupus.
Study examines the effects of the antimalarial drug, hydroxycloroquine, on antiphospholipid antibodies that are responsible for pregnancy complications in women with lupus and antiphospholipid syndrome.
Lupus Foundation of America medical director Dr. Joan Merrill discusses a recently completed a study that may help to improve the design for future lupus clinical trials and secure approval of new safe and more tolerable treatments for lupus.